Survey: Most regional investors want a better due diligence process
April 7, 2017 | Meghan LeVota
For investors, investigating deals isn’t always an easy process.
From examining an industry’s opportunity to loads of legal analysis, the amount of work in the due diligence process is often enough to deter financiers from investing in a firm.
That’s why in a recent survey, a majority of regional investors said they’d love a better way to conduct due diligence. Conducted by KCSourceLink and the Alternative Investment Forum, the survey found that almost two-thirds of regional investors say it would be helpful to have a standardized due diligence process for venture offerings.
“In the spring of 2016 we did a survey with KCSourceLink to find out why some investors were reluctant to invest in early stage entrepreneurial deals,” said AIF co-founder Mark Meyerdirk. “One of the major findings of that survey was that new investors don’t know how to properly investigate deals. Based on this finding we decided to do a follow-up survey at the end of 2016 of professional investors, who do this for a living, to see if there was a standardized due diligence process.”
The organizations asked 41 regional funds and investors — such as KCRise fund, Fulcrum Global Capital and Brown Cow Capital — about what the due diligence process looks like for them. Often, the biggest expense is time, the survey revealed.
The study showed that 85 percent of investors spend more than 20 hours conducting due diligence per venture opportunity considered. 36 percent spend more than 60 hours on each potential deal.
Most commonly, investors vet the target company by asking the management team for data, reviewing legal and financial details, analyzing the intellectual property and reviewing industry competition.
“Insights into what investors look for helps us educate both investors and entrepreneurs to create a better process for accessing capital in Kansas City,” KCSourceLink founder Maria Meyers said in a release.
The survey concluded that many regional investors may be interested in outsourcing due diligence work.
That’s why AIF and KCSourceLink are teaming up to create a Venture Stage Due Diligence Report Template, based on that recent data the survey secured. In addition, Meyerdirk said he will approach the Ewing Marion Kauffman Foundation with the possibility of conducting a similar survey on a national scale.
To read the full report, click here.

2017 Startups to Watch
stats here
Related Posts on Startland News
2022 Kansas City’s VC-Backed Companies Report
The metro’s field of venture capital-backed companies is getting more crowded — their payrolls swelling with new employees — amid a bounce-back from the global pandemic and new signals of Kansas City’s momentum, according to data in a new report from Startland News. The 2022 Kansas City Venture Capital-Backed Companies Report provides an updated snapshot into…
Sicilian legacy meats its match: Why this rising star on KC’s food scene was DiCapo’s pick to take over family pizzeria after nearly 100-year run
As a teenager working in downtown Kansas City in the 1990s, Theresa Santos found herself spending her breaks and spare time at the Italian Gardens restaurant on 12th and Baltimore, she recalled. Growing up in New York City and infatuated with Italian culture and food, Santos quickly became friends with the staff — then the…
You shouldn’t have to drive through hell to find a car, founder says; Startup brings concierge service to online auto customers
Not all car buyers want to be in the driver’s seat — especially when attempting to navigate a disconnected roadmap of dealer-focused online marketplaces, said Eric Westphal. “Years ago, when I was looking for a car, I knew what I wanted and I couldn’t find it locally,” said Westphal, describing the inspiration behind Overland Park-based…
‘Perfect for new mRNA vaccines’: Olathe startup targets biotech toward precision delivery
A sudden, then lingering, global pandemic put a spotlight on vaccine technology — with an Olathe startup now positioning itself at the leading edge of both pharmaceutical and vaccine applications for humans and their four-legged counterparts. “We manufacture and develop peptide delivery systems to help deliver drugs and vaccines safer and more effectively,” said Steve…
